Oral Delivery of Biologics
On 29th Aug 2020, CRSIC conducted 2nd National level webinar titled “Oral Delivery of Biologics”. Dr. Yogeshwar Bacchav, Founder Director, Adex Pharma & Co-opted member of Executive Committee, CRSIC was an invited resource person for this technical talk. Oral delivery of biologics like proteins, peptides, and hormones especially insulin has always been a topic of great interest and extensive research. During his talk, Dr. Yogeshwar first presented the challenges in the oral delivery of biologics and then explained formulation strategies investigated so far, to overcome these challenges. His lucid and informative talk acquainted the participants with the latest nanotechnology based carriers and the advanced medical devices that are being explored for the effective oral delivery of the biologics.
Dr. Yogeshwar BacchavFounder Director, Adex Pharma & Co-opted member of Executive Committee, CRSIC
Dr. Yogeshwar Bachhav is a Pharmacist by training. After completing PhD in Pharmaceutics from the Institute of Chemical Technology, Mumbai (Formerly UDCT), he worked in Europe (DACH region) for around 15 years with different start up and mid-size biotech and pharmaceutical companies.
During this tenure, he has successfully managed pharmaceutical development of several projects from POC to phase 1, 2 and 3 clinical trials. He has Strong network of Experts and CDMOs in EU, USA and Asia. In addition, he has 16 international publications, 8 patents and 30 conference proceedings to his credit. Recently he has edited a book for Wiley-VCH (Germany) on “Innovative Dosage Form, Design and Development at Early Stage”. Dr. Bachhav has been invited as a speaker for many international symposia around the globe (India, Europe and US).
He is a full time consultant with a German Biotech company -AiCuris Anti-infective Cures since 2014. There he is responsible to deal with pharmaceutical development of new drugs in anti-infectives segment.
In addition, Yogesh has founded a Pharmaceutical R&D consultancy firm – Adex Pharma in 2016. The prime objective of Adex is to resolve complex issues in the Pharmaceutical development of new drugs (INDs) and life cycle management of approved drugs (NDAs/ANDAs). He also supports few clients in India to resolve the CMC issues.
Dr. Bacchav is a member of the executive committee of Controlled Release Society-Indian Chapter.